![Mark Schlegel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Mark Schlegel worked as a Senior Scientist at Alnylam Pharmaceuticals, Inc. from 2016 to 2018.
Former job includes Senior Scientist at Alnylam Pharmaceuticals, Inc.
Former positions of Mark Schlegel
| Companies | Position | End |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2018-11-30 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
- Stock Market
- Insiders
- Mark Schlegel
